SCHEMBL7983628

SCHEMBL7983628

Cc1cc(C)c(-c2ccc(N)c3c2nc(N)c2cncn23)c(C)c1

nearest known ligand 0.39

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LCK P06239 4/20 0.39
SRC P12931 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7980338 0.92 LCK (0.39) LCK
SCHEMBL7987372 0.90 LCK (0.48) LCKSRC
SCHEMBL7981166 0.86 LCK (0.36) LCK
SCHEMBL7979911 0.85 LCK (0.36) LCK
SCHEMBL7987236 0.81 LCK (0.36) LCK
SCHEMBL3284326 0.72 CRHR1 (0.33)
SCHEMBL8472491 0.68 LCK (0.44) LCKSRC
SCHEMBL3286995 0.66 SMN1; SMN2 (0.50) LCK
SCHEMBL4042248 0.65 PRMT5 (0.33) LCK
SCHEMBL7969763 0.65 LCK (0.53) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed